Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ULORIC safely and effectively. See full prescribing information for ULORIC. ULORIC (febuxostat) tablets, for oral useInitial U.S. Approval: 2009
Medication labelWhy this: Advisory · dailymed-prescription
ULORIC is a xanthine oxidase (XO) inhibitor indicated for the chronic management of hyperuricemia in adult patients with gout who have an inadequate response to a maximally titrated dose of allopurinol, who are intolerant to allopurinol, or for whom treatment with allopurinol is not advisable. Limitations of Use: ULORIC is not recommended for the treatment of asymptomatic hyperuricemia.
- generic_name
- febuxostat
- product_names
- febuxostat
- ndc
- 64764-918, 64764-918-30, 64764-918-90, 64764-918-18, 64764-918-11, 64764-677, 64764-677-30, 64764-677-13, 64764-677-19, 64764-677-11
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en